ULISSE BIOMED SPA (UBM.MI) Stock Earnings & Estimates
Europe - Euronext Milan - BIT:UBM - IT0005451213 - Common Stock
0.8 EUR
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 138.4K -49.96% | 66.2K -52.17% | 767.9K 1,059.97% | 1.01M 31.53% | 2.02M 100.00% | 5.05M 150.00% | |
| EBITDA YoY % growth | -986.8K -177.42% | -2.293M -132.41% | -2.988M -30.28% | -1.01M 66.20% | -1.01M | 100.00% | |
| EBIT YoY % growth | -1.306M -116.51% | -4.797M -267.15% | -5.911M -23.24% | -1.01M 82.91% | -1.01M | 100.00% | |
| Operating Margin | -943.93% | -7,245.47% | -769.77% | -100.00% | -50.00% | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -0.04 | -0.03 8.11% | 0.00 102.94% |
All data in EUR
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 528.8K 42.57% | % | ||
| Q4 2024 Q2Q % growth | 397.1K 692.61% | % | ||
| Q2 2024 Q2Q % growth | 370.9K 2,203.73% | % | ||
| Q4 2023 Q2Q % growth | 50.1K -33.02% | % | ||
| Q2 2023 Q2Q % growth | 16.1K -74.73% | % | ||
| Q4 2022 Q2Q % growth | 74.8K -42.81% | % | ||
| Q2 2022 Q2Q % growth | 63.7K -56.31% | % | ||
| Q4 2021 Q2Q % growth | 130.8K -69.40% | % | ||
| Q2 2021 Q2Q % growth | 145.8K 12,050.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | 9.76% |
| Revenue | N/A | N/A | 0% | 0% |